HCC recurrence in HCV-infected patients after liver transplantation: SiLVER Study reveals benefits of sirolimus in combination with CNIs - a post-hoc analysis.

Werner, Jens M; Hornung, Matthias; Krah, Rubertha; Götz, Markus; Schnitzbauer, Andreas A; Schlitt, Hans J; Geissler, Edward K

Werner, Jens M; Hornung, Matthias; Krah, Rubertha; Götz, Markus; Schnitzbauer, Andreas A; Schlitt, Hans J; Geissler, Edward K.

Afiliação

Werner JM; Department of Surgery, University Hospital Regensburg, Regensburg, Germany.
Hornung M; Department of Surgery, University Hospital Regensburg, Regensburg, Germany.
Krah R; Department of Surgery, University Hospital Regensburg, Regensburg, Germany.
Götz M; Department of Surgery, University Hospital Regensburg, Regensburg, Germany.
Schnitzbauer AA; Department of Surgery, University Hospital Regensburg, Regensburg, Germany.
Schlitt HJ; Department of Surgery, University Hospital Frankfurt, Frankfurt am Main, Germany.
Geissler EK; Department of Surgery, University Hospital Regensburg, Regensburg, Germany.

Transpl Int ; 33(8): 917-924, 2020 08.

Article em En | MEDLINE | ID: mdl-32314828

Assuntos

Carcinoma Hepatocelular; Hepatite C; Neoplasias Hepáticas; Transplante de Fígado; Hepatite C/tratamento farmacológico; Humanos; Recidiva Local de Neoplasia; Prata; Sirolimo/uso terapêutico

Palavras-chave

Silver Study; direct-acting antiviral agents; hepatitis C virus infection; hepatocellular carcinoma; liver transplantation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Fígado / Hepatite C / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Transpl Int Assunto da revista: TRANSPLANTE Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google